A Mendelian randomization study revealed that genetically predicted endogenous testosterone is positively linked to cardiovascular disease (CVD), including thromboembolism, heart failure (HF), and myocardial infarction (MI) in men. The study identified genetic predictors of endogenous testosterone from a genome wide association study of serum testosterone conducted in 3225 men of European ancestry aged 50-75. The predictors were assessed in 392 038 white British men and women aged 40-69. In men, endogenous testosterone genetically predicted by variants in the JMJD1C gene region was positively associated with thromboembolism (odds ratio per unit increase in log transformed testosterone (nmol/L) 2.09) and HF (7.81), but not MI (1.17). Associations were less obvious in women. The findings were validated in 171 875 patients of about 77% European descent, in that genetically predicted testosterone (based on JMJD1C gene region variants) was positively associated with MI (1.37). However, testosterone genetically predicted by potentially pleiotropic variants in SHBG gene region had no association with the outcomes. The findings are consistent with other studies and provide another strand of evidence in sex hormone related mechanisms in CVD. Source: https://www.bmj.com/
Two recent studies highlight the importance of physical activity volume and intensity in reducing cardiovascular…
A prospective UK cohort study found that both self-reported average or brisk walking pace and…
A U.S. randomized clinical trial found that 4:3 intermittent fasting (IMF) led to slightly greater…
A Danish nationwide cohort study provided real world evidence that both glucagon-like peptide 1 receptor…
A systematic review and meta-analysis of placebo-controlled randomized trials showed that there is moderate certainty…
A US cohort study indicated that statin use may reduce the risks of hepatocellular carcinoma…
This website uses cookies.